Haass, A <br/><br/>
[Dextran 40 or HES 200/0.5? Hemorheology of the long-term treatment of ischemic cerebral attacks].  [electronic resource] 

 -  Deutsche medizinische Wochenschrift (1946)  Oct 1986 
 - 1681-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0012-0472 
<br/><br/><label>Standard No.: </label>10.1055/s-2008-1068692  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Viscosity--drug effects<br/>Cerebral Infarction--blood<br/>Clinical Trials as Topic<br/>Dextrans--therapeutic use<br/>Hemodilution<br/>Humans<br/>Hydroxyethyl Starch Derivatives--therapeutic use<br/>Random Allocation<br/>Starch--analogs & derivatives<br/>Time Factors